世界のエピナスチン市場規模・現状・予測2021-2027

【英語タイトル】Global Epinastine Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR2237)・商品コード:QY21APR2237
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:98
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、エピナスチンの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(錠剤、カプセル、点眼薬)、用途別市場規模(結膜炎、アレルギー、喘息、湿疹、通年性アレルギー性鼻炎、季節性アレルギー性鼻炎、乾癬、そう痒症、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・エピナスチンの市場動向
・企業の競争状況、市場シェア
・エピナスチンの種類別市場規模(錠剤、カプセル、点眼薬)
・エピナスチンの用途別市場規模(結膜炎、アレルギー、喘息、湿疹、通年性アレルギー性鼻炎、季節性アレルギー性鼻炎、乾癬、そう痒症、その他)
・エピナスチンの北米市場規模2016-2027(アメリカ、カナダ)
・エピナスチンの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・エピナスチンのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・エピナスチンの中南米市場規模2016-2027(メキシコ、ブラジル)
・エピナスチンの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Santen、Merck、Daiichi Sankyo、Allergan、Akorn、Amneal Pharmaceuticals、Apotex Corp、Cypress Pharmaceuticals、Boehringer Ingelheim)
・結論
【レポートの概要】

Epinastine is used for the prevention of itching associated with allergic conjunctivitis. It has a multi-action effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to control the allergic response, 2. prevents histamine binding to both the H1- and H2-receptors to stop itching and provide lasting protection, and 3. prevents the release of proinflammatory chemical mediators from the blood vessel to halt progression of the allergic response.

Market Analysis and Insights: Global Epinastine Market
The global Epinastine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epinastine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epinastine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epinastine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epinastine market.

Global Epinastine Scope and Market Size
Epinastine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epinastine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets
Capsule
Eye Drops

Segment by Application
Conjunctivitis
Allergy
Asthma
Eczema
Perennial Allergic Rhinitis
Seasonal Allergic Rhinitis
Psoriasis
Pruritus
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Santen
Merck
Daiichi Sankyo
Allergan
Akorn
Amneal Pharmaceuticals
Apotex Corp

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epinastine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Eye Drops
1.3 Market by Application
1.3.1 Global Epinastine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Conjunctivitis
1.3.3 Allergy
1.3.4 Asthma
1.3.5 Eczema
1.3.6 Perennial Allergic Rhinitis
1.3.7 Seasonal Allergic Rhinitis
1.3.8 Psoriasis
1.3.9 Pruritus
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epinastine Market Perspective (2016-2027)
2.2 Epinastine Growth Trends by Regions
2.2.1 Epinastine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epinastine Historic Market Share by Regions (2016-2021)
2.2.3 Epinastine Forecasted Market Size by Regions (2022-2027)
2.3 Epinastine Industry Dynamic
2.3.1 Epinastine Market Trends
2.3.2 Epinastine Market Drivers
2.3.3 Epinastine Market Challenges
2.3.4 Epinastine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epinastine Players by Revenue
3.1.1 Global Top Epinastine Players by Revenue (2016-2021)
3.1.2 Global Epinastine Revenue Market Share by Players (2016-2021)
3.2 Global Epinastine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epinastine Revenue
3.4 Global Epinastine Market Concentration Ratio
3.4.1 Global Epinastine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epinastine Revenue in 2020
3.5 Epinastine Key Players Head office and Area Served
3.6 Key Players Epinastine Product Solution and Service
3.7 Date of Enter into Epinastine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epinastine Breakdown Data by Type
4.1 Global Epinastine Historic Market Size by Type (2016-2021)
4.2 Global Epinastine Forecasted Market Size by Type (2022-2027)

5 Epinastine Breakdown Data by Application
5.1 Global Epinastine Historic Market Size by Application (2016-2021)
5.2 Global Epinastine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epinastine Market Size (2016-2027)
6.2 North America Epinastine Market Size by Type
6.2.1 North America Epinastine Market Size by Type (2016-2021)
6.2.2 North America Epinastine Market Size by Type (2022-2027)
6.2.3 North America Epinastine Market Size by Type (2016-2027)
6.3 North America Epinastine Market Size by Application
6.3.1 North America Epinastine Market Size by Application (2016-2021)
6.3.2 North America Epinastine Market Size by Application (2022-2027)
6.3.3 North America Epinastine Market Size by Application (2016-2027)
6.4 North America Epinastine Market Size by Country
6.4.1 North America Epinastine Market Size by Country (2016-2021)
6.4.2 North America Epinastine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Epinastine Market Size (2016-2027)
7.2 Europe Epinastine Market Size by Type
7.2.1 Europe Epinastine Market Size by Type (2016-2021)
7.2.2 Europe Epinastine Market Size by Type (2022-2027)
7.2.3 Europe Epinastine Market Size by Type (2016-2027)
7.3 Europe Epinastine Market Size by Application
7.3.1 Europe Epinastine Market Size by Application (2016-2021)
7.3.2 Europe Epinastine Market Size by Application (2022-2027)
7.3.3 Europe Epinastine Market Size by Application (2016-2027)
7.4 Europe Epinastine Market Size by Country
7.4.1 Europe Epinastine Market Size by Country (2016-2021)
7.4.2 Europe Epinastine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epinastine Market Size (2016-2027)
8.2 Asia-Pacific Epinastine Market Size by Type
8.2.1 Asia-Pacific Epinastine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epinastine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epinastine Market Size by Type (2016-2027)
8.3 Asia-Pacific Epinastine Market Size by Application
8.3.1 Asia-Pacific Epinastine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epinastine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epinastine Market Size by Application (2016-2027)
8.4 Asia-Pacific Epinastine Market Size by Region
8.4.1 Asia-Pacific Epinastine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epinastine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epinastine Market Size (2016-2027)
9.2 Latin America Epinastine Market Size by Type
9.2.1 Latin America Epinastine Market Size by Type (2016-2021)
9.2.2 Latin America Epinastine Market Size by Type (2022-2027)
9.2.3 Latin America Epinastine Market Size by Type (2016-2027)
9.3 Latin America Epinastine Market Size by Application
9.3.1 Latin America Epinastine Market Size by Application (2016-2021)
9.3.2 Latin America Epinastine Market Size by Application (2022-2027)
9.3.3 Latin America Epinastine Market Size by Application (2016-2027)
9.4 Latin America Epinastine Market Size by Country
9.4.1 Latin America Epinastine Market Size by Country (2016-2021)
9.4.2 Latin America Epinastine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epinastine Market Size (2016-2027)
10.2 Middle East & Africa Epinastine Market Size by Type
10.2.1 Middle East & Africa Epinastine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epinastine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epinastine Market Size by Type (2016-2027)
10.3 Middle East & Africa Epinastine Market Size by Application
10.3.1 Middle East & Africa Epinastine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epinastine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epinastine Market Size by Application (2016-2027)
10.4 Middle East & Africa Epinastine Market Size by Country
10.4.1 Middle East & Africa Epinastine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epinastine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Santen
11.1.1 Santen Company Details
11.1.2 Santen Business Overview
11.1.3 Santen Epinastine Introduction
11.1.4 Santen Revenue in Epinastine Business (2016-2021)
11.1.5 Santen Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Epinastine Introduction
11.2.4 Merck Revenue in Epinastine Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Details
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Epinastine Introduction
11.3.4 Daiichi Sankyo Revenue in Epinastine Business (2016-2021)
11.3.5 Daiichi Sankyo Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Epinastine Introduction
11.4.4 Allergan Revenue in Epinastine Business (2016-2021)
11.4.5 Allergan Recent Development
11.5 Akorn
11.5.1 Akorn Company Details
11.5.2 Akorn Business Overview
11.5.3 Akorn Epinastine Introduction
11.5.4 Akorn Revenue in Epinastine Business (2016-2021)
11.5.5 Akorn Recent Development
11.6 Amneal Pharmaceuticals
11.6.1 Amneal Pharmaceuticals Company Details
11.6.2 Amneal Pharmaceuticals Business Overview
11.6.3 Amneal Pharmaceuticals Epinastine Introduction
11.6.4 Amneal Pharmaceuticals Revenue in Epinastine Business (2016-2021)
11.6.5 Amneal Pharmaceuticals Recent Development
11.7 Apotex Corp
11.7.1 Apotex Corp Company Details
11.7.2 Apotex Corp Business Overview
11.7.3 Apotex Corp Epinastine Introduction
11.7.4 Apotex Corp Revenue in Epinastine Business (2016-2021)
11.7.5 Apotex Corp Recent Development
11.8 Cypress Pharmaceuticals
11.8.1 Cypress Pharmaceuticals Company Details
11.8.2 Cypress Pharmaceuticals Business Overview
11.8.3 Cypress Pharmaceuticals Epinastine Introduction
11.8.4 Cypress Pharmaceuticals Revenue in Epinastine Business (2016-2021)
11.8.5 Cypress Pharmaceuticals Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Epinastine Introduction
11.9.4 Boehringer Ingelheim Revenue in Epinastine Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epinastine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Capsule
Table 4. Key Players of Eye Drops
Table 5. Global Epinastine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Epinastine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Epinastine Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Epinastine Market Share by Regions (2016-2021)
Table 9. Global Epinastine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Epinastine Market Share by Regions (2022-2027)
Table 11. Epinastine Market Trends
Table 12. Epinastine Market Drivers
Table 13. Epinastine Market Challenges
Table 14. Epinastine Market Restraints
Table 15. Global Epinastine Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Epinastine Market Share by Players (2016-2021)
Table 17. Global Top Epinastine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epinastine as of 2020)
Table 18. Ranking of Global Top Epinastine Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Epinastine Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Epinastine Product Solution and Service
Table 22. Date of Enter into Epinastine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Epinastine Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Epinastine Revenue Market Share by Type (2016-2021)
Table 26. Global Epinastine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Epinastine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Epinastine Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Epinastine Revenue Market Share by Application (2016-2021)
Table 30. Global Epinastine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Epinastine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Epinastine Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Epinastine Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Epinastine Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Epinastine Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Epinastine Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Epinastine Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Epinastine Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Epinastine Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Epinastine Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Epinastine Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Epinastine Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Epinastine Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Epinastine Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Epinastine Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Epinastine Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Epinastine Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Epinastine Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Epinastine Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Epinastine Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Epinastine Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Epinastine Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Epinastine Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Epinastine Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Epinastine Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Epinastine Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Epinastine Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Epinastine Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Epinastine Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Epinastine Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Epinastine Market Size by Country (2022-2027) & (US$ Million)
Table 62. Santen Company Details
Table 63. Santen Business Overview
Table 64. Santen Epinastine Product
Table 65. Santen Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 66. Santen Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Epinastine Product
Table 70. Merck Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Daiichi Sankyo Company Details
Table 73. Daiichi Sankyo Business Overview
Table 74. Daiichi Sankyo Epinastine Product
Table 75. Daiichi Sankyo Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 76. Daiichi Sankyo Recent Development
Table 77. Allergan Company Details
Table 78. Allergan Business Overview
Table 79. Allergan Epinastine Product
Table 80. Allergan Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 81. Allergan Recent Development
Table 82. Akorn Company Details
Table 83. Akorn Business Overview
Table 84. Akorn Epinastine Product
Table 85. Akorn Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 86. Akorn Recent Development
Table 87. Amneal Pharmaceuticals Company Details
Table 88. Amneal Pharmaceuticals Business Overview
Table 89. Amneal Pharmaceuticals Epinastine Product
Table 90. Amneal Pharmaceuticals Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 91. Amneal Pharmaceuticals Recent Development
Table 92. Apotex Corp Company Details
Table 93. Apotex Corp Business Overview
Table 94. Apotex Corp Epinastine Product
Table 95. Apotex Corp Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 96. Apotex Corp Recent Development
Table 97. Cypress Pharmaceuticals Company Details
Table 98. Cypress Pharmaceuticals Business Overview
Table 99. Cypress Pharmaceuticals Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 100. Cypress Pharmaceuticals Recent Development
Table 101. Boehringer Ingelheim Company Details
Table 102. Boehringer Ingelheim Business Overview
Table 103. Boehringer Ingelheim Epinastine Product
Table 104. Boehringer Ingelheim Revenue in Epinastine Business (2016-2021) & (US$ Million)
Table 105. Boehringer Ingelheim Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epinastine Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Capsule Features
Figure 4. Eye Drops Features
Figure 5. Global Epinastine Market Share by Application: 2020 VS 2027
Figure 6. Conjunctivitis Case Studies
Figure 7. Allergy Case Studies
Figure 8. Asthma Case Studies
Figure 9. Eczema Case Studies
Figure 10. Perennial Allergic Rhinitis Case Studies
Figure 11. Seasonal Allergic Rhinitis Case Studies
Figure 12. Psoriasis Case Studies
Figure 13. Pruritus Case Studies
Figure 14. Others Case Studies
Figure 15. Epinastine Report Years Considered
Figure 16. Global Epinastine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Epinastine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Epinastine Market Share by Regions: 2020 VS 2027
Figure 19. Global Epinastine Market Share by Regions (2022-2027)
Figure 20. Global Epinastine Market Share by Players in 2020
Figure 21. Global Top Epinastine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epinastine as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Epinastine Revenue in 2020
Figure 23. Global Epinastine Revenue Market Share by Type (2016-2021)
Figure 24. Global Epinastine Revenue Market Share by Type (2022-2027)
Figure 25. North America Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Epinastine Market Share by Type (2016-2027)
Figure 27. North America Epinastine Market Share by Application (2016-2027)
Figure 28. North America Epinastine Market Share by Country (2016-2027)
Figure 29. United States Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Epinastine Market Share by Type (2016-2027)
Figure 33. Europe Epinastine Market Share by Application (2016-2027)
Figure 34. Europe Epinastine Market Share by Country (2016-2027)
Figure 35. Germany Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Epinastine Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Epinastine Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Epinastine Market Share by Region (2016-2027)
Figure 45. China Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Epinastine Market Share by Type (2016-2027)
Figure 53. Latin America Epinastine Market Share by Application (2016-2027)
Figure 54. Latin America Epinastine Market Share by Country (2016-2027)
Figure 55. Mexico Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Epinastine Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Epinastine Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Epinastine Market Share by Country (2016-2027)
Figure 61. Turkey Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Epinastine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Santen Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 66. Daiichi Sankyo Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 67. Allergan Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 68. Akorn Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 69. Amneal Pharmaceuticals Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 70. Apotex Corp Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 71. Cypress Pharmaceuticals Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 72. Boehringer Ingelheim Revenue Growth Rate in Epinastine Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed


【掲載企業】

Santen、Merck、Daiichi Sankyo、Allergan、Akorn、Amneal Pharmaceuticals、Apotex Corp、Cypress Pharmaceuticals、Boehringer Ingelheim

★調査レポート[世界のエピナスチン市場規模・現状・予測2021-2027] (コード:QY21APR2237)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエピナスチン市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆